Note: Ingredients listed on restricted chemical lists
EC/CAS
232-151-5/7789-23-3
Name of the chemical
Potassium fluoride
Concentration
<10%
General Information
Version
UK Page 1 of 13
Revision date
2023-07-09
Product name
HTRF S1/ACE2 Bind. kit - Ctrl 64BDS1TDA
1.2.1 Relevant identified uses
Use of the substance or mixture for Laboratory Research use only ;
1.2.2. Uses advised against
Do not use for diagnostics, therapeutics or other clinical uses. ;
supplier name
CISBIO BIOASSAYS, company of Revvity Group
Emergency telephone
France - Numéro ORFILA (INRS) : + 33 (0)1 45 42 59 59
Icons in SDS
Company Information
company name
CISBIO BIOASSAYS, company of Revvity Group
e-mail address of the competent person responsible for the Safety Data Sheet
codolet.sds@revvity.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H332
Hazard statements
Code
Statements
H332
Harmful if inhaled
Section 2
SECTION 2: Hazards identification
Precautionary statements
P261 Acute toxicity - Acute Tox. 4 - H332 - Inhalation P271 Acute Tox. 4 H332 P304 + P340 P312
2.2 Label elements
Labelling
Product definition
Designation / Commercial name : HTRF S1/ACE2 Bind. kit - Ctrl 64BDS1TDA Substances contained in this product: Substance name CAS n° Index n° EC n° Version UK Page 2 of 13 Revision Date: 07/09/2023 potassium fluoride 7789-23-3 009-005-00-2 232-151-5
Hazard pictograms
GHS07-exclam
Signal word
Warning Hazard and precautionary statements: Code Hazard statments H332 Harmful if inhaled P261 Avoid breathing dust/fume/gas/mist/vapours/spray. P271 Use only outdoors or in a well-ventilated area. P304 + P340 IF INHALED: Remove person to fresh air and keep comfortable for breathing. P312 Call a POISON CENTRE/doctor/… if you feel unwell.
2.3 Other hazards
The mixture does not contain substances classified as ‘Substances of Very High Concern' (SVHC) >= 0.1% published by the European CHemicals Agency (ECHA) under article 57 of REACH. The mixture satisfies neither the PBT nor the vPvB criteria for mixtures in accordance with annexe XIII of the REACH regulations EC
Potential health effects
Version UK Page 3 of 13 Revision Date: 07/09/2023